FFFlávio Geraldo Rezende de Freitas

Flávio Geraldo Rezende de Freitas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Flávio Geraldo Rezende de Freitas has a total of 168 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prospective, randomized, controlled trial assessing the effects of methylene blue for the prevention of hypotension during renal replacement therapy: protocol paper and statistical analysis plan for the BLUE study

    by Carla Daniele Nascimento Pontes, Fernando Godinho Zampieri, Rodrigo Cruvinel Figueiredo, Rodolpho Augusto de Mouro Pedro, Luiz Marcelo Sá Malbouisson, Rodrigo Camillo da Cunha, Fernando Jose da Silva Ramos, Lucas Petri Damiani, Bruno Adler Maccagnan Pinheiro Besen, Flávio Geraldo Rezende de Freitas, et al.

    To describe the study protocol and statistical analysis plan that will be used to evaluate whether methylene blue reduces interventions aimed at controlling hypotension during renal replacement therapy as compared to usual care. BLUE is a randomized, multicenter, open-label trial. Patients with high risk of hypotension during renal replacement therapy will be randomized to receive either methylene blue infusion at a dose of 1mg/kg as a bolus, followed by continuous infusion of 0.1mg/kg of body weight in a total of 200mL of saline solution throughout the dialysis session, or to usual care. The usual care group will not receive any intervention. A total of 260 patients is expected to be randomized in a 1:1 ratio. The primary outcome will be a composite of any of the following events: (1) initiation of vasopressor therapy or an increase of at least 20% from baseline dose; (2) interruption of the renal replacement therapy session; or (3) interruption of fluid removal at the request of the attending physician at any point during the session. Secondary outcomes include the occurrence of hypotension during the hemodialysis session, the maximum vasopressor dose within the first 24 hours, intensive care unit mortality, and in-hospital mortality. The BLUE study will provide evidence on the role of methylene blue in preventing hypotension during renal replacement therapy.

  • Propofol versus Ketamine in rapid sequence intubation in critically ill patients: a prospective, randomized, controlled trial

    by Raysa Cristina Schmidt, Fernando Godinho Zampieri, Fernando Jose da Silva Ramos, Felipe Santos Cavatoni Serra, Bruno Adler Maccagnan Pinheiro Besen, Nathaly Fonseca Nunes, Daniela Boschetti, Fernanda Chohfi Atallah, Miriam Jackiu, Livia Maria Garcia Melro, et al.

    Purpose The optimal hypnotic agent for rapid sequence intubation (RSI) in critically ill patients remains uncertain. We evaluated whether Ketamine is a better alternative than propofol. Methods In this investigator-initiated, randomized, controlled, open-label trial conducted in two mixed ICU, adults (≥ 18 years) requiring RSI were assigned 1:1 to Ketamine or propofol. The primary outcome was the lowest mean arterial pressure (MAP) within the first 10 min after induction, analyzed with a linear regression model adjusted for age, baseline MAP, and total vasopressor dose within 10 min. Results From October 2021 to October 2023, 207 patients were randomized and 175 were included in the modified intention-to-treat analysis. The lowest MAP within 10 min was 66 (55–79) mmHg with Ketamine and 60 (48–72) mmHg with propofol (mean difference, 6.0 [95% CI − 0.0 to 11.9]; p = 0.050). The average MAP difference over the first hour was 1.67 (95% CI − 1.98 to 5.31). Cardiovascular collapse occurred in 20/91(22%) Ketamine-treated patients and 28/84 (33%) receiving propofol, mainly due to an increase in the vasopressor dose within 2 min. Day-7 mortality was 33% with Ketamine and 23.8% with propofol (OR 1.38; 95% CI 0.86–2.24). Hospital mortality was 60.4% and 50.0%, respectively (OR 1.21; 95% CI 0.92–1.58). Conclusions Among critically ill patients undergoing RSI, Ketamine resulted in a less pronounced decrease in MAP in the first 10 min compared with propofol, but the difference was not clinically meaningful or sustained. These findings challenge sedative selection based solely on perceived risk of hypotension and highlight the need for larger trials to determine the optimal induction agent. Clinicaltrials.gov registry NCT05092152—initial release 10.13.2021. Visual abstract


  • Open Access

    Contemporary validation of a SAPS 3 customized version in patients admitted to Brazilian and Uruguayan intensive care units: a multicenter cohort study

    by Marcio Soares, Lunna Perdigão Borges, Gastón Burghi, Pedro Kurtz, José Raimundo Araújo de Azevedo, Carlos Eduardo Brandão, Aloysio Saulo Breves Beiler, Niklas Soderberg Campos, Liane Oliveira Cavalcante, Mario Diego Teles Correia, et al.

    Objective: To compare the performance of the standard equation (SAPS 3-SE) and a customized version (SAPS 3-Custom) of the Simplified Acute Physiology Score 3 in a contemporary cohort of Brazilian and Uruguayan intensive care unit patients. Methods: We conducted a retrospective cohort study of 262,198 adults admitted to 177 intensive care units between 2022 […] ABSTRACT Objective: To compare the performance of the standard equation (SAPS 3-SE) and a customized version (SAPS 3-Custom) of the Simplified Acute Physiology Score 3 in a contemporary cohort of Brazilian and Uruguayan intensive care unit patients. Methods: We conducted a retrospective cohort study of 262,198 adults admitted to 177 intensive care units between 2022 […]


  • Open Access

    Prospective, randomized, controlled trial comparing PROpofol versus KetaMINE in rapid sequence intubation in critically ill patients (PROMINE): protocol paper and statistical analysis plan

    by Raysa Cristina Schmidt, Fernando Godinho Zampieri, Fernando Jose da Silva Ramos, Felipe Santos Cavatoni Serra, Lucas Petri Damiani, Flávio Geraldo Rezende de Freitas, Flávia Ribeiro Machado

    Background: The optimal and safest hypnotic agent for rapid sequence intubation in critically ill patients remains uncertain. Factors such as hypovolemia, vasoplegia, hypoxemia, and acidosis can influence the efficacy and safety of induction agents. Propofol is commonly used for this purpose; however, it is associated with the risk of exacerbating hypotension. Ketamine, which has […] ABSTRACT Background: The optimal and safest hypnotic agent for rapid sequence intubation in critically ill patients remains uncertain. Factors such as hypovolemia, vasoplegia, hypoxemia, and acidosis can influence the efficacy and safety of induction agents. Propofol is commonly used for this purpose; however, it is associated with the risk of exacerbating hypotension. Ketamine, which has […]


  • Open Access

    Brazilian Research in Intensive Care Network (BRICNet): shaping the landscape of critical care research in Brazil and beyond

    by Juliana Carvalho Ferreira, Adriano José Pereira, Alexandre Biasi Cavalcanti, Antonio Paulo Nassar, Ary Serpa, Bruno Adler Maccagnan Pinheiro Besen, Bruno Martins Tomazini, Cassiano Teixeira, Felipe Dal-Pizzol, Fernando Augusto Bozza, et al.

    Critical illnesses such as sepsis and acute respiratory distress syndrome lead to millions of deaths globally, with a higher burden in low- and middle-income countries. Conducting multicentric clinical studies is essential to help minimize the burden of critical illnesses, particularly in areas where their impact is greater. However, conducting large-scale multicentric studies is challenging, […] ABSTRACT Critical illnesses such as sepsis and acute respiratory distress syndrome lead to millions of deaths globally, with a higher burden in low- and middle-income countries. Conducting multicentric clinical studies is essential to help minimize the burden of critical illnesses, particularly in areas where their impact is greater. However, conducting large-scale multicentric studies is challenging, […]


  • Open Access

    Prevalence and risk factors of Burnout syndrome among intensive care unit members during the second wave of COVID-19: a single-center study

    by Verena Laila Moniz Barreto Lima, Fernando José da Silva Ramos, Paulo Henrique Suher, Maria Aparecida Souza, Fernando Godinho Zampieri, Flavia Ribeiro Machado, Flavio Geraldo Resende de Freitas

    Highlights A single-center study evaluated the prevalence and risk factors for Burnout syndrome in intensive care unit teams. The study revealed a high prevalence of Burnout syndrome in at least one dimension. Factors such as profession and having two or more jobs were associated with severe burnout symptoms. The study highlighted the need for interventions and support to address burnout among intensive care unit teams. ABSTRACT Objective: To evaluate the prevalence of burnout among the intensive care unit team of


  • Open Access

    Assessment of the components of fluid balance in patients with septic shock: a prospective observational study

    by Maria Aparecida de Souza, Fernando José da Silva Ramos, Bianca Silva Svicero, Nathaly Fonseca Nunes, Rodrigo Camillo Cunha, Flavia Ribeiro Machado, Flavio Geraldo Rezende de Freitas


  • Open Access

    Variações na pressão venosa central durante um desafio volêmico têm valor limitado para orientar a terapia com fluidos

    by Priscilla Souza de Oliveira, Fernando José da Silva Ramos, Daniere Yurie Vieira Tomotani, Flávia Ribeiro Machado, Flávio Geraldo Rezende de Freitas

    RESUMO Objetivo: Avaliar se as variações na pressão venosa central durante a expansão volêmica e a variação respiratória cíclica basal na curva de amplitude da pressão venosa central poderiam ser usadas para discriminar entre pacientes responsivos e não responsivos a fluidos. Métodos: Trata-se de um estudo observacional prospectivo que incluiu pacientes adultos em estado crítico que foram submetidos à expansão volêmica na forma de infusão volêmica ou desafio volêmico de cristaloides. Todos os pacientes estavam em ventilação mecânica e devidamente sedados. Determinamos a pressão venosa central basal (PVCT0) e as variações em 5 (ΔPVCT5), 10 (ΔPVCT10) e 15 (ΔPVCT15) minutos durante a infusão volêmica. Também medimos a curva de amplitude da PVCT0. Definiu-se a responsividade a fluidos como um aumento do índice cardíaco de ≥ 15%. Resultados: O estudo incluiu 30 pacientes (11 responsivos e 19 não responsivos). A PVCT0 e as variações após um desafio volêmico em todos os três momentos não previram adequadamente a capacidade de resposta a fluidos, conforme determinado por seus valores de área sob a curva (PVCT0: 0,70, IC95% 0,49 - 0,90; ΔPVCT5: 0,78, IC95% 0,57 - 0,99; ΔPVCT10: 0,63, IC95% 0,39 - 0,88; ΔPVCT15: 0,68; IC95% 0,45 - 0,92). A curva de amplitude da PVCT0 também teve um desempenho insatisfatório (área sob a curva: 0,70; IC95% 0,50 - 0,91). Conclusão: As variações na pressão venosa central têm valor limitado na previsão da responsividade a fluidos.

  • Open Access

    Changes in central venous pressure during a fluid challenge have limited value for guiding fluid therapy

    by Priscilla Souza de Oliveira, Fernando José da Silva Ramos, Daniere Yurie Vieira Tomotani, Flávia Ribeiro Machado, Flávio Geraldo Rezende de Freitas

    Objective: To evaluate whether changes in central venous pressure during fluid expansion and baseline cyclic respiratory variation in the central venous pressure amplitude (RespCVP) curve could be used to discriminate between fluid responders and nonresponders. Methods: This prospective observational study included critically ill adult patients who underwent fluid expansion in the form of a fluid bolus or fluid challenge with crystalloids. All patients were under mechanical ventilation and adequately sedated. We determined the central venous pressure at baseline (CVPT0) and the changes at 5 (ΔCVPT5), 10 (ΔCVPT10) and 15 (ΔCVPT15) minutes during fluid infusion. We also measured the RespCVP at baseline. Fluid responsiveness was defined as a cardiac index increase of ≥ 15%. Results: The study included 30 patients (11 responders and 19 nonresponders). The CVPT0 and the changes after a fluid challenge at all three time points did not adequately predict fluid responsiveness, as determined by their area under the curve values (CVPT0: 0.70, (95%CI: 0.49 - 0.90; ΔCVPT5: 0.78, (95%CI: 0.57 - 0.99; ΔCVPT10: 0.63, (95%CI: 0.39 - 0.88; ΔCVPT15: 0.68, ((95%CI: 0.45 - 0.92). The RespCVP at baseline also had a poor performance (area under the curve: 0.70; 95%CI: 0.50 - 0.91). Conclusion: Changes in central venous pressure have limited value in predicting fluid responsiveness.


  • Open Access

    Resuscitation fluid practices in Brazilian intensive care units: a secondary analysis of Fluid-TRIPS

    by Flavio Geraldo Rezende de Freitas, Naomi Hammond, Yang Li, Luciano Cesar Pontes de Azevedo, Alexandre Biasi Cavalcanti, Leandro Taniguchi, Andrã© Gobatto, Andrã© Miguel Japiassãº, Antonio Tonete Bafi, Bruno Franco Mazza, et al.

    To describe fluid resuscitation practices in Brazilian intensive care units and to compare them with those of other countries participating in the Fluid-TRIPS. This was a prospective, international, cross-sectional, observational study in a convenience sample of intensive care units in 27 countries (including Brazil) using the Fluid-TRIPS database compiled in 2014. We described the patterns of fluid resuscitation use in Brazil compared with those in other countries and identified the factors associated with fluid choice. On the study day, 3,214 patients in Brazil and 3,493 patients in other countries were included, of whom 16.1% and 26.8% (p < 0.001) received fluids, respectively. The main indication for fluid resuscitation was impaired perfusion and/or low cardiac output (Brazil: 71.7% versus other countries: 56.4%, p < 0.001). In Brazil, the percentage of patients receiving crystalloid solutions was higher (97.7% versus 76.8%, p < 0.001), and 0.9% sodium chloride was the most commonly used crystalloid (62.5% versus 27.1%, p < 0.001). The multivariable analysis suggested that the albumin levels were associated with the use of both crystalloids and colloids, whereas the type of fluid prescriber was associated with crystalloid use only. Our results suggest that crystalloids are more frequently used than colloids for fluid resuscitation in Brazil, and this discrepancy in frequencies is higher than that in other countries. Sodium chloride (0.9%) was the crystalloid most commonly prescribed. Serum albumin levels and the type of fluid prescriber were the factors associated with the choice of crystalloids or colloids for fluid resuscitation.